High purity ≥99% triple GLP-1/GIP/Glucagon receptor agonist. The most advanced multi-receptor peptide for metabolic research. Factory direct with full documentation.
Factory direct pricing with no middlemen. Bulk discounts available for research institutions and biotech companies.
Get Discount PriceRetatrutide represents the next generation of incretin-based research compounds. As a triple hormone receptor agonist, it simultaneously targets GLP-1, GIP, and glucagon receptors — offering a unique multi-pathway approach to metabolic research.
This synthetic peptide analog is designed for advanced metabolic studies, providing researchers with a powerful tool to investigate energy homeostasis, glucose metabolism, and body weight regulation through multiple complementary mechanisms.
Key Features:
Retatrutide is utilized in cutting-edge metabolic research, including studies on:
Note: This product is intended for laboratory research use only. Not for human consumption, diagnostic, or therapeutic applications.
Every batch of Retatrutide undergoes comprehensive testing to ensure the highest standards for research applications.